Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Gastrointestinal Neoplasms 1

Interventions

Drug Therapy 4apatinib 3Oxaliplatin 3pemigatinib 2pembrolizumab 2cemiplimab 2avelumab 2atezolizumab 2S 1 (combination) 2Nivolumab 2Leucovorin 2Irinotecan 2Folfox protocol 2Fluorouracil 2Everolimus 2Erlotinib Hydrochloride 2Endoscopic Mucosal Resection 2Docetaxel 2Capecitabine 2CGX1321 2vandetanib 1titanium silicide 1tepotinib 1tegafur-gimeracil-oteracil 1talazoparib 1sodium thiosulfate 1selpercatinib 1rucaparib 1pralsetinib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Neoplasms × tegafur-gimeracil-oteracil × Clear all
NCT01608646 2012-05-31

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Xijing Hospital

Phase 2 Unknown
200 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡